Avasopasem manganese(Synonyms: GC-4419; M-40419)

发表于由

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白，专注于信号通路和疾病研究领域。

Avasopasem manganese (Synonyms: GC-4419; M-40419)

Avasopasem manganese (GC4419;M-40419) 是一种有效的超氧化物歧化酶，能迅速和特异性地将 O2*- 转化为过氧化氢 (H2O2)，阻止这一级联反应的启动。Avasopasem manganese 可用于严重口腔黏膜炎 (SOM) 和癌症的研究。

Avasopasem manganese(Synonyms: GC-4419; M-40419)

Avasopasem manganese Chemical Structure

CAS No. : 435327-40-5

规格 价格 是否有货
5 mg ￥8000 询问价格 & 货期
10 mg ￥13000 询问价格 & 货期

* Please select Quantity before adding items.

生物活性

Avasopasem manganese (GC4419; M-40419) is a potent superoxide dismutase mimetic that rapidly and specifically converts O2*- to hydrogen peroxide (H2O2), arresting the initiation of this cascade. Avasopasem manganese can be used for the research of severe oral mucositis (SOM) and cancer[1].

体内研究
(In Vivo)

Avasopasem manganese is an agent intended to interrupt severe oral mucositis pathogenesis, to reduce the duration, incidence, and severity of radiation-induced oral mucositis[1].

Shanghai Jinpan Biotech Co Ltd has not independently confirmed the accuracy of these methods. They are for reference only.
Clinical Trial

分子量

479.35

Formula

C21H31Cl2MnN5
CAS 号

435327-40-5
运输条件

Room temperature in continental US; may vary elsewhere.
储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.
参考文献

  • [1]. Anderson CM, et al. Phase IIb, Randomized, Double-Blind Trial of GC4419 Versus Placebo to Reduce Severe Oral Mucositis Due to Concurrent Radiotherapy and Cisplatin For Head and Neck Cancer [published correction appears in J Clin Oncol. 2020 Jan 20;38(3):288]. J Clin Oncol. 2019;37(34):3256-3265.

所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务